Total number of patients | 45 |
Age (years) | 27.1 ± 9.6 |
Sex | Â |
Male | 19 |
Female | 26 |
Race/ethnicity | Â |
White | 19 |
South Asian | 13 |
Arabic | 8 |
African | 5 |
Units of blood transfused (units/year) | 32.2 ± 17.3 |
Past history cardiac disease | Â |
Heart Failure | 5 (11%) |
Time between heart failure and scan (years) | 3.7 ± 7.6 |
Arrhythmia | 4 (9%) |
Time between arrhythmia and scan (years) | 4.0 ± 6.7 |
CMR measures: | Â |
Cardiac T2* (ms) median (Q1, Q3) | 22.6 (13.4, 34.5) |
Liver T2* (ms) median (Q1, Q3) | 4.4 (2.3, 8.5) |
LV end diastolic volume (mL) | 134 ± 41.4 |
LV end systolic volume (mL) | 46.4 ± 20.2 |
LV ejection fraction (%) | 65.8 ± 8.5 |
Chelation | Â |
Deferoxamine only | 21 (47%) |
Deferiprone only | 3 (7%) |
Deferasirox only | 9 (20%) |
Deferoxamine & deferiprone | 11 (24%) |
No Chelation | 1 (2%) |